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ABSTRACT

Perinatal substance use (PSU) is a serious and growing public health concern. It is
associated with a variety of adverse health outcomes for both mother and child and has
been shown to negatively impact the parent-child relationship. Despite the growing
prevalence of PSU, there are notable deficits in provider knowledge regarding, and
comfortability with, PSU. Moreover, providers report feelings of judgment, resentment,
fear, and hesitancy related to their work with women with PSU. Subsequently, women
with PSU struggle to find appropriate, compassionate, and effective treatment for their
substance misuse. Widespread and accessible training is needed to bolster provider
knowledge base, reduce stigma, shame, and increase quality of service provision and care
for women with PSU. This paper aims to outline the development and structure of a PSU
training to serve as a one model to expand knowledge, competency, and awareness for
the PSU workforce. I begin with a review of the prevalence of PSU and its impact on
maternal and infant wellbeing. Theoretical underpinnings of PSU are explored, including
a specific discussion regarding the interplay between the neurobiology of addiction and
the parent-child attachment system. Subsequently, the current state of the PSU workforce
and the need for training is discussed. The paper ends with an in-depth review of a PSU
training developed in collaboration with the University of Denver, Colorado Department
of Public Health (CDPH), and the Colorado chapter of Postpartum Support International
(PSI). Implications for the field and potential future directions are explored.

INTRODUCTION
Perinatal substance use (PSU; i.e., substance use during pregnancy and the first
year postpartum) is a serious and growing public health concern in the United States
(Deutsch et al., 2021). PSU poses significant risks for both mother and child, including
increased rates of maternal and infant mortality, developmental delays, and long-term
health impairments (i.e., learning disabilities, mental health difficulties, and regulatory
concerns) (Kramlich et al., 2018; Maralit et al., 2022; Renbarger et al., 2020).
Prevalence rates of PSU are difficult to accurately estimate due to maternal
concerns related to stigma, policy, mandating reporting, and the subsequent risk of child
welfare involvement. Current data suggests that alcohol, cannabis, and tobacco are the
most common substances used during pregnancy (Forray et al., 2016). Of approximately
4 million births in 2017, 8% (340,000 infants) were born affected by illicit substances,
12% (460,000 infants) were born alcohol exposed, and 15% (588,000 infants) were born
exposed to tobacco (Deutsch et al., 2021). In addition, in the last decade alone the
prevalence of births associated with opioid use disorders (OUD) has quadrupled,
increasing from 1.5 per every 1,000 deliveries to 6.5 per every 1,000 deliveries (Schiff et
al., 2017). Marijuana use and stimulant use during pregnancy have followed a similar
increasing pattern, with recent reports showing 4.2% and 3.4% (respectively) of pregnant
women reporting use (Smid et al., 2019; Ko et al., 2020). While it is likely that current
prevalence rates underestimate the true scope of the issue, it is evident that the frequency
of PSU is on the rise.
PSU is associated with determinantal risks to both mother and child including
labor and delivery concerns (i.e., stillbirth, preterm birth, low birth weight, SIDS, etc.),

maternal viral infections, and birth defects (Maralit et al., 2022; Renbarger et al., 2020).
Neonatal Abstinence Syndrome (NAS) (i.e., postnatal opioid withdrawal) is associated
with infant dysregulation, hyperirritability of the central and autonomic systems, tremors,
weight loss, and seizures (Kramlich et al., 2018). Fetal Alcohol Spectrum Disorders
(FASDs) are associated with various long term health impacts including executive
functioning difficulty, learning impairments, decreased impulse control, and mental
health concerns including ADHD, depression, anxiety, future substance misuse, and
increased likelihood of incarceration later in life (Maralit et al., 2022).
Due to concerns for infant wellbeing, many pregnant women report a significant
reduction and/or cessation of substance use during pregnancy. However, recent
prevalence? data demonstrates a steep increase in substance use between six months to
one year postpartum, when infant-maternal bonding is crucial for development (Forray et
al., 2016).
RACIAL AND ETHNIC DISPARITIES
PSU exacerbates the already overwhelming racial inequities related to maternal
and infant health and wellbeing (Le & Coombs, 2021). While literature clearly
demonstrates that women across income levels and racial/ethnic groups are equally
susceptible to developing a substance use disorder, there are vast disparities in current
screening, assessment, and reporting practices related to PSU (Benoit et al., 2014;
Wallman et al., 2011). Pregnant women of color are both more likely to be screened and
assessed for substance use concerns and more likely to subsequently be reported to child
welfare services than white women (Benoit et al., 2014; Garg et al., 2010; Le & Coombs,
2021). The biased screening and assessment practices arbitrarily inflate reported

prevalence rates of PSU for women of color reinforcing inaccurate and racist beliefs
regarding patterns of substance misuse in communities of color (Stone, 2015).
Both historical and current oppressive policies and practices perpetuate patterns of
for fear and hesitancy regarding the health care system women of color and result in a
low standard of care for women of color with PSU (Le & Coombs, 2021). Moreover,
biased screening and reporting practices contribute to the long-standing criminalization of
women of color and reinforce patterns of intergenerational trauma and psychological pain
(Garg et al., 2010; Le & Coombs, 2021; Maralit et al., 2022).

WHAT TO EXPECT WHEN YOU’RE EXPECTING… AND IN RECOVERY
Substance use disorders have historically been conceptualized as a siloed concern
(i.e., separated from other areas within behavioral health) (Bell & McCutcheon, 2020).
While this reductionistic approach is problematic for individuals with substance use
disorders in a general sense, it is particularly determinantal for women with PSU. Given
the unique etiology, clinical presentations, challenges and needs of women with PSU, a
holistic understanding is imperative for effective treatment and support.
Expecting or newly parenting mothers with PSU face an exorbitant amount of
shame and stigma. They tend be viewed as morally corrupt, selfish, and sexually
irresponsible due to their “choice” to have a child while in active addiction (Nichols et
al., 2020). However, the road to PSU is much more nuanced than it would appear on the
surface. To start, women are more quickly susceptible than men to developing the disease
state of addiction. A phenomenon referred to as telescoping details how, in general,
smaller doses of the substance for shorter periods of time are required for women to

develop an addiction to their drug of choice. Moreover, women tend to experience higher
levels of cravings, making it more difficult for them to maintain sobriety (National
Institute on Drug Abuse, 2020). Further, prolonged patterns of substance misuse
dysregulate menstrual cycles, increasing the likelihood of unplanned or unrecognized
pregnancy (Speroff & Fritz, 2005). Thus, what on the surface appears to be reckless
decision to enter parenting while in addiction is in actuality a highly complicated
interaction between genetics, addictive substances, neurobiology, and hormones.
In addition to the unique etiology of addiction in women, the underlying
mechanisms behind why perinatal women (and individuals more generally) use
substances is largely misunderstood. The popularly held belief is that an individual uses
drugs to illicit a “high” (i.e., euphoria, extreme relaxation, boosted mood, etc.). However,
emerging research has demonstrated that, while substances may generate a high
sensation, the motivation for use is more directly related to the human need for
connection, safety, and regulation (Khantzian et al., 2014; Tippett, 2020).
Research has clearly demonstrated the relationship between attachment and
addiction. Our attachment system and regulatory systems are interconnected; meaning, it
is through the intersection of these systems that we cope, manage, and regulate our
distress (Parolin & Simonelli, 2016). Attachment and regulatory patterns are established
within our relationship with our primary caregivers in early childhood. Insecure
attachments, very generally, occur when a caregiver struggles to provide a child with
adequate comfort when they are distressed. That child will likely then struggle to learn
effective strategies to cope on their own, resulting in long term regulatory deficits,
limited coping skills, and insecure patterns of relating to others and their world (Guyon-

Harris et al., 2022). Substances effectively, and often rather quickly, manage and quiet
internal distress, replacing the regulatory deficits resulting from an insecure attachment
(Khantzian et al., 2014; Padykula & Conklin, 2010). From this perspective, patterns of
substance abuse are, at their core, simply an attempt to find safety and stability in a world
that feels uncertain and dangerous.
IMPLICATIONS FOR THE PARENT-CHILD RELATIONSHIP
The intersection of the neurobiology of addiction and attachment has direct
implications for treatment, recovery, and the parent-child relationship (Guyon-Harris et
al., 2022; Parolin & Simonelli, 2016). As discussed above, substance use disorders can be
conceptualized as an attempt to compensate for insecure attachment histories and
regulatory deficits. While substances may serve to temporarily conceal or quiet distress,
an insecure attachment can result in a host of other emotional deficits that are not
mitigated by substance use. For instance, an individual with an insecure attachment
history may find they have limited emotional awareness and reflective functioning
capacity, and struggle to connect and attune to other’s emotional experience (Lyden et al.,
2013; Goodman et al., 2008). These deficiencies can hinder a mother’s ability to attune to
her infant’s emotional experience which, in turn, impacts the parent-child relationship
and impedes the development of a secure attachment.
Women with PSU report feelings of distance and lack of connection to their
infant, as well as feelings of shame and inadequacy as they do not seem to experience the
same levels of maternal-infant bond as their peers (Guyon-Harris et al., 2022). However,
this feeling of disconnection is likely unrelated to a lack of desire for closeness with their
baby. Rather, it stems from the enduring neurobiological effects of substance misuse.

Prolonged substance use has the capacity to impair prefrontal cortical functioning
and leave individuals more vulnerable to stress. A history of substance misuse lowers
levels of dopamine in the brain, subsequently shifting the neural circuity related to reward
and motivation by producing less dopamine to accommodate for the influx from excess
substance use (Volkow et al., 2016). Stated more simply, individuals feel less natural
motivation to work through stressful situations given the absence (or limited nature) of a
reward (i.e., dopamine) following completion.
These deficits have direct implications for parenting as dopamine is a key factor
in maternal motivation and behavior (Rutherford et al., 2013; Suchman et al., 2011;
Parolin & Simonelli, 2016). Mothers with PSU will likely experience less intrinsic
motivation to care for their distressed baby, which, without proper support and treatment,
can hinder the developing parent-child relationship. Moreover, the shifts in dopamine
production leave mothers with PSU more vulnerable to the impact of parenting-related
stress, which can in turn result in higher cravings and increased likelihood of relapse
(Rutherford et al., 2013; Suchman et al., 2011; Parolin & Simonelli, 2016). In sum,
attachment and regulatory deficits related to substance misuse transmit across generations
and create problems for the mother, the child, and the parent-child dyad (Lyden et al.,
2013).

THE NEED FOR TRAINING
Pregnancy and the postpartum period present a prime opportunity for effective
treatment of PSU. Mothers are more likely to engage in prenatal care, seek substance use
and mental health treatment, and stay engaged in treatment due to their desire to care for
their baby (Kissin et al., 2004). Early and active involvement in prenatal care and

treatment have been shown to mitigate some of the health risks associated with PSU,
improve maternal-infant relationship quality, and has demonstrated the potential to
dismantle intergenerational cycles of attachment insecurity (Lynden et al, 2013; Kramlich
et al, 2020; Renbarger et al., 2019). Recognizing the importance of intervention during
this period, the American College of Obstetrics and Gynecologist (ACOG) and the
American Academic of Pediatrics (AAP) currently recommend universal substance use
screening to identify women and families in need of services. However, it is often not
addressed or discussed due to provider lack of familiarity or comfort level (Garg et al.,
2015; Deutsch et al., 2021).
Moreover, despite clear research that specialized treatment for PSU is the most
effective, tailored treatment options for women with PSU are largely limited (Coiffi et al.,
2019; Clark et al., 2001). Most providers do not receive specific training in PSU and
subsequently may not feel comfortable or competent working within this subset of the
population (Maralit et al., 2022). Bell and McCutcheon (2020) reviewed the lack of
adequate substance use training within psychology training programs. Their work
concluded that psychologists continue to be trained to view substance use disorders as
separate from mental health, perpetuating patterns of psychologists’ feelings of
incompetency and fear regarding working with clients with substance use disorders (Bell
& McCutcheon, 2020). A similar theme is found throughout medical providers’
experience of their training related to PSU. Pediatric training, for both medical students
and nurses, rarely highlights the unique considerations for caring for a substance exposed
dyad (Schiff et al., 2017). The lack of sufficient training results in medical providers
feeling overwhelmed, burdened, fearful, and resistant to treat women with PSU (Nicholas

et al., 2020; Clarke et al., 2015; Marcellus, 2014). In addition, there are notable deficits in
both medical and behavioral health provider knowledge regarding PSU, its impact on the
mother-infant dyad, and the relationship between PSU and psycho-social determinants of
health (i.e., health problems, poverty, violence, trauma, etc.) (Howlett et al., 2019;
Marcellus, 2014). Many women with PSU describe significant gaps in their own
understanding of how PSU may impact their pregnancy, as well as feelings of shock and
disbelief following delivery as they witness their babies’ PSU related health difficulties
and withdrawal. Without a strong provider knowledge base to learn from, mothers are left
isolated and unsure of how advocate for their health care and wellbeing (Kramlich et al.,
2018).
THE ROLE OF STIGMA AND SHAME
The stigma and shame associated with PSU pose a major barrier to access,
engagement, and retention in treatment (Schiff et al., 2017). As noted above, providers’
biases are generally founded on the misconceived notion that mothers with PSU have
complete and total agency over their substance use and health. These internalized biases
have the power to influence provider perception of their patient/client, subsequently
leading them to view PSU as a morally deviant and irresponsible life choice (Benoit et
al., 2014). Many women with PSU describe interactions with their providers as
“judgmental, disparaging, scrutinizing, [and] disempowering” (Renbarger et al., 2020).
The shame experienced within appointments with their providers exacerbates the
degradation and stigma they experience within the culture at large, reinforcing their
tendency to avoid disclosing their substance use, delay treatment, and continue engaging
in risky behaviors (Benoit et al., 2014; Paris et al., 2020; Livingston et el., 2011).

Conversely, a provider – patient/client relationship that is founded in trust, emotional
safety, and openness is clearly associated with better treatment outcomes and increased
likelihood of long-term recovery (Kramlich et al., 2018). Research has demonstrated that
increased education, training, and exposure to PSU can reduce stigma/bias and increase
comfort level of providers, which in turn leads to better patient care and improved
outcomes (Maralit et al., 2022).
In sum, the educational deficits and shame-based practices have direct, negative,
implications for the health and wellbeing of the mother, child, and their relationship.
Widespread and accessible training is needed to bolster provider knowledge base, reduce
stigma and shame, and increase quality of service provision and care for women with
PSU. Thus, this paper aims to outline the development and structure of a PSU training to
serve as a one model to expand knowledge, competency, and awareness for the PSU
workforce.

METHODS
The PSU training model was created in collaboration with the University of
Denver, Colorado Department of Public Health (CDPH), and Postpartum Support
International (PSI). Training development was spearheaded by the University of Denver
team (this author, Dr. Tracy Vozar, Dr. Kelly Lavin, and Dr. John Holmberg).
Team members from CDPH (Jessica Bass, Kallen Thorton, and Kacey Bernard)
and PSI (Kristin Aaker) reviewed training material throughout stages of development to
provide feedback and constructive guidance. Psychologists and psychiatrists with content
expertise in maternal behavioral health and perinatal substance use disorders (Dr. Patrece
Hairston Peetz and Dr. Kaylin Klie) reviewed the training as well to provide additional

feedback. Team members from CDPH organized logistics related to training scheduling,
securing a location to host the training, and advertisement and enrollment for the event.
CURATING THE CONTENT
In preparation for the development of this training, a thorough review of current
literature related to perinatal mental health, infant mental health, attachment, PSU, and
provider knowledge base, perception, and comfort with PSU was conducted. In addition,
current available trainings related to PSU were reviewed. Information gained from the
literature and current available trainings were utilized to inform and develop this training.
Given the vast nature of available literature, included content and themes needed
to be carefully considered and selected. The team established four main learning
objectives to refine content selection: (1) increase general understanding, knowledge
base, and comfortability with PSU; (2) increase contextual understanding of PSU,
including its intersection with social determinants of health, multicultural considerations,
and mother-infant relationships; (3) provide introductory knowledge regarding theoretical
perspectives on PSU and how they impact your community and practice; and, (4)
increase understanding of resources, referrals, and tools that can employed while working
with patients/clients with PSU.
CONSIDERATIONS REGARDING THE TARGET AUDIENCE
Prior to starting the content development stage, we worked to thoughtfully
consider the most appropriate and effective target audience for the training. Literature has
clearly documented the benefit of integrated, multidisciplinary, and holistic treatment
services for women with PSU (Benoit et al., 2014; Crane et al, 2019; Sahker et al., 2015;
Tarasoff et al., 2018). Thus, the training was intentionally designed to be delivered to a

multidisciplinary audience of health care providers that work with mothers, children, and
families (i.e., nurses, doctors, psychiatrists, psychologists, social workers, home visitors,
etc.). Content was curated to provide an accessible overview of PSU and introductory
content with the aim of increasing provider comfortability and knowledge base and
reducing stigma.

RESULTS
The following section reviews the training structure, including the four developed
training modules and their aims.
USE OF CLINICAL CASE VINGETTES
Clinical vignettes were utilized throughout the training to help illustrate the lived
experiences of mothers with PSU. At the start of the training, participants are introduced
to three women: Olivia, Emily, and Sara (pseudonyms utilized). The women’s stories
represent a range of clinical presentations of PSU. Olivia, for instance, began using
opioids when she was 12 years old, stealing pain pills from her mother’s cabinet. Her use
escalated throughout the years to heroin and eventually methamphetamine. Emily’s story
highlights a notably different journey through PSU. Her first experience of substance
misuse did not occur until her mid-thirties, following the birth of her 4th child when she
was prescribed pain pills by her OBGYN due to complications from labor and delivery.
The third mother’s story, Sara, illuminates her struggle with alcohol abuse after moving
to a small town for her partner’s job. The clinical vignettes grow in complexity and depth
throughout the training. As participants move through the learning modules, they learn
more about the three women as it relates to the knowledge base covered in the module.
Participants are asked to reflect upon the women’s stories throughout the training,

noticing if, and how, their perceptions of them shift as the gain more knowledge and
understanding. The clinical vignettes are designed with the hope of enhancing participant
empathy, understanding, and supporting participants in contextualizing PSU within the
larger structure of an individual’s life, and in turn increasing relatability and decreasing
stigma.
MODULE 1: UNDERSTANDING PERINATAL SUBSTANCE USE (PSU): AN
INTRODUCTION TO SUBSTANCE USE DURING THE PERINATAL PERIOD
Given the multidisciplinary target audience, the intention of the first module is to
lay foundational knowledge blocks regarding PSU that can be built upon throughout the
training. This includes a review of epidemiology and prevalence rates. Since this training
was developed for a Colorado audience, prevalence rates across the United States (figure
1) and specifically related to Colorado (figure 2) are included.

Figure 1

Figure 2

In addition, DSM-5 TR substance use disorder diagnostic criteria is reviewed.
Risk factors and correlates, such as epigenetics, chronic pain, family current use and
history of use, life experiences, social determinants of health, trauma, and comorbid
disorders are discussed (Brown et al., 2019; Roos et al., 2012). Finally, an introduction to
the neurobiology of PSU and gender specific differences within addiction is provided.
This includes a brief review of shifts in neurobiology related to prolonged substance use
and its impacts on parenting (as discussed above).
MODULE 2: SOCIAL JUSTICE, SYSTEMIC RACISM, AND SUBSTANCE USE
DISORDERS
The second module has two aims: (1) to provide an educational overview of
systemic and structural racism and its impact on substance misuse and (2) to invite
participants to reflect upon their own biases and the impact bias may have on their work
with mothers with PSU. The four levels of structural, institutional, interpersonal, and
individual racism are utilized to promote discussion and reflection related to PSU and
maternal behavioral health (figure 3). Specific discussion of biased screening, reporting

practices, and deficient treatment practices within communities of color impacted by PSU
are discussed. In addition, participants are invited to reflect and question their own biases
and experiences across the levels of racism. Opportunities for large group and small
group discussion are provided.

Figure 3; Strategic plan 2021-2022 – tlcdeaf.org.

MODULE 3: EXPLORING THE INTERSECTION BETWEEN SUBSTANCE MISUSE
AND OUR REGULATORY SYSTEM
The overarching aim of the third module is to bolster participants’ contextual
understanding of PSU, with the goal of increasing compassion and empathy, as well as
reducing stigma and bias regarding PSU. Facilitators explore the theoretical
underpinnings of PSU, guiding participants through a discussion of attachment theory,
regulatory systems, and their combined impact on clinical presentations of PSU and
parent-child relationships.

It begins with a brief introduction to attachment theory and its relationship with
substance use disorders. Figure 4 is utilized to provide an overarching framework of
attachment theory, focusing on the impact of attachment on future relationships and
functioning. Utilizing the graphic, training facilitators discuss how individuals within the
secure category would be expected to have a self-competent view of self and a view of
others (i.e., relationship in their life, the world in general) as dependable and safe.
Subsequently, facilitators review how individuals with secure attachments are, generally,
able to successfully manage distress. Contrastingly, the preoccupied, dismissing, and
fearful categories are discussed highlighting the deficits in an individual’s model of self,
model of others, or both, and their impacts on regulation capacity (Bowlby, 1979).
Facilitators then review how substances are utilized to mitigate deficits across the three
insecure categories (Khantzian et al., 2014).

Figure 4, With thanks to S. Stuart & J. Shultz, IPT Institute

Training facilitators subsequently lead participants through a discussion of the
impacts of PSU on the maternal-infant relationship. Specific focus and attention are given
to the intergenerational transmission of attachment insecurity and mental health concerns
(Lynden et al., 2013). Utilizing figures 4 and 5, facilitators discuss the cyclical

relationship between attachment insecurity, substance misuse, parenting, and infant wellbeing and development.

Figure 4

Figures 5

The module ends with a discussion of gender-responsive and trauma-informed
care. Research has clearly demonstrated that gender responsive care improves substance
use related treatment outcomes (Grella, 2008; Meyers et al., 2020). As such, facilitators
review the role gender plays in the course of substance use disorders, treatment
engagement and retention, and recovery. Specific time and consideration is given to the
unique gender considerations related to PSU, including pregnancy, labor and delivery,
and motherhood. The principals of gender responsive care are reviewed, including (1)
“services that are safe and responsive to client needs, (2) responsive to, and reflective of,
peoples’ lived experiences, needs, preferences, identities, and circumstances, (3)
physical, sexual, and emotional safety, (4) recognition that women and men may
experience mental health issues differently, and (5) staff education and training to
promote gender sensitivity across policies, systems, and practices.” (Department of
Health, Vitoria, 2022). As gender responsive care practices highlight the importance of
relationships, participants are guided through a discussion consideration how they may
utilize gender responsive care while treating PSU and the mother-infant dyad.
Finally, the importance of trauma-informed care is reviewed. The link between
childhood adversity, trauma, and substance use is discussed, including the increase
likelihood of early initiation of alcohol, higher risk of mental health difficulties and
substance misuse, increased risk of prescription substance use, and increased likelihood
of lifetime illicit drug use (Leza et al., 2021; Marcellus, 2014). The principals of trauma
informed care, including safety, trustworthiness and transparency, peer support,
collaboration and mutuality, empowerment and choice, and intersectionality (Bowen &
Murshid, 2016). Facilitators discuss the benefits of utilizing a trauma-informed approach

for PSU including promotion of strong maternal-infant bonding and attachment,
decreased stress/anxiety, and increased engagement in services. Additionally, the
benefits on trauma-informed care on provider wellbeing is reviewed, including decreased
vicarious trauma, improved provider-patient/client relationships, and increased provider
satisfaction (Marcellus, 2014).
MODULE 4: A JOURNEY THROUGH PERINATAL SUBSTANCE USE:
SCREENING, REFERRALS, TREATMENT & POLICY
The fourth module aims to walk participants through an individual journey with
PSU, giving participants the opportunity to contextualize an individual’s experience of
seeking treatment, receiving referrals, and entering recovery and parenting with PSU.
Additionally, the fourth module aims to increase provider understanding of best screening
practices, policy considerations, and the continuum of care.
Education regarding the differences between screening (i.e., process of gathering
more information from patients about their substance use, with a self-administered or
clinician-administered validated screening tool) and toxicology testing (i.e., collection of
a biological sample looking for the presence of a drug or its metabolite) is provided. In
addition, facilitators guide discussion regarding the importance of universal, traumainformed, and gender responsive screening practices. (Garg et al., 2015; Deutsch et al.,
2021). Participants are provided with a table of resources and suggestions for screening
measures (figure 6).

Screening Tools for Perinatal Substance Use
Measure name
Constructs Assessed Items
Perinatal Specific Tools
4P’s Plus
triggers for
7 plus
substance use/ abuse, follow
follow-up for
up
quantity
5P’s
substance use by 5 plus 2
women’s parents, follow
peers, partner, during up
her pregnancy and in
her past
SURP-P
Marijuana & alcohol 3 items
use; desire to cut
down

Clinical Threshold

Citation

affirmative
response to any of
the last four items

Chasnoff et al.,
2007

affirmative
response to any
item suggests
follow-up needed

Massachusetts
Institute for
Health and
Recovery, 1999

one affirmative
response =
moderate risk, 2-3
affirmative
responses = highrisk for substance
use

Yonkers et al.,
2010

Substance Use Tools Non-specific to Perinatal Period
CAGE
Heavy alcohol use; 4 items score of two or
modified to include
greater
drug use (CAGEAID)
TWEAK
harmful drinking
5 items score of two or
habits in pregnant
greater
women
T-ACE
Identifiers of risky 4 items score of two or
and harmful alcohol
greater
use
AUDIT-C
Identifiers of risky 3 items Score of three or
alcohol use
greater
NIDA-ASSIST
Use of alcohol,
2 parts, lower risk (scores
tobacco products,
4 items 0–3), moderate risk
non-medical need- & 8
(scores 4–26), or
based prescription items high risk (scores 27
drugs, illegal drugs;
or higher)
frequency &
impairment related
to use
Figure 6

Ewing, 1984

Chan et al., 1993

Sokol, 1988

Bush et al., 1998
NIDA, 2009

As this training was designed for a Colorado audience, Colorado statutes related
to substance exposed newborns and child welfare are discussed. Within the state of
Colorado, a mandated reporter is not required to report knowledge of substance use in
pregnancy, be it suspected, self-reported, or discovered via toxicology, to child welfare.
While child welfare reports are intended (generally) to serve in the best interest of mother
and baby, they are not frequently perceived that way. Facilitators lead an interactive
discussion regarding the implications of the decision to, or to not, report on the provider –
patient/client relationships. Discussion questions include: (1) “How might your decision
to report PSU be perceived?”; (2) “How might your decision not to report be perceived?”;
and (3) “How might your patient/client’s attachment history impact the way you share
your decision?”. The aim of the exercise is to encourage providers to consider the
complex nature of mandatory reporting and consider ways to center gender responsive,
trauma-informed, and attachment-based perspectives as they navigate discussions
regarding reporting.
Many training participants may later find themselves responsible for coordinating
referrals and treatment for patients/clients with PSU. To strengthen provider knowledge
base related to referral options and increase likelihood of provider capacity to arrange
effective referrals, the continuum of care and treatment options for PSU are reviewed.
Specific attention and time are given to the discussion of medication assisted treatment
(MAT) and its implications for pregnancy, breast feeding, and maternal-infant wellbeing.
Benefits of MAT are reviewed including increased adherence to prenatal care, decreased
illicit drug use, improved nutrition, improved neonatal birth weight, decreased maternal
mortality (figure 7), and decreased risk-taking behaviors (Jones et al., 2012)

Figure 7; Mittal, L. (2020)

The module ends with a review of various treatment options including detox,
inpatient/residential treatment, partial hospitalization, intensive outpatient, outpatient
therapy, and support group models {e.g., Alcoholics Anonymous (AA), Narcotics
Anonymous (NA)]. General aims, treatment approaches, and conditions of each level of
treatment are reviewed. In addition, characteristics and clinical presentations of a
“typical” patient/client referred to each level of care is discussed (e.g., substance abuse
severity). Finally, facilitators guide participants through an interactive discussion on
strategies to decide treatment fit in which participants are presented with brief clinical
vignettes and asked to consider which level of care may be most appropriate.
USE OF DISCUSSION AND REFLECTION OPPORTUNITIES
Throughout the four modules, discussion questions and reflection opportunities
are used to increase participant engagement and promote internalization of training

material. Discussion questions have two general aims: (1) encouraging participants to
consider how the material learned in the module impacts policy and practice and (2)
inviting participants to consider how the information applies to their specific community
and scope of practice. Reflection opportunities are designed to add a personal and
introspective aspect to their learning. Reflective questions include topics such as
welcoming participants to consider their personal reactions to clinical vignettes (i.e.,
judgements, empathy, assumptions), question their perception of competency and
comfort level working within this population, and be curious regarding the way these
experiences did or did not shift throughout the training.

DISCUSSION AND FUTURE DIRECTIONS
This paper aimed to outline the development and structure of a PSU training to
serve as one model for expanding knowledge, competency, and awareness for the PSU
workforce. While this paper is not intended to be a step-by-step guide for training
development, the following paragraphs are utilized to review key pieces of advice for
professionals considering developing and disseminating their own training, as well as
next steps for this project.
The collaboration of teams across the University of Denver, CDPH, and PSI were
key to the success of training development. The multidisciplinary team structure allowed
for thoughtful, and accessible, content creation that could be utilized by a diverse group
of providers. Professionals considering developing and disseminating PSU trainings
within their communities should seek out multidisciplinary partnerships for support,
guidance, and feedback. In addition, the partnerships established with content experts
were imperative to ensure training quality. Our content expert partners provided an

invaluable lens related to their specific areas of focus. They each were able to review our
training from a unique outlook, founded in years of specific training and experience.
Their knowledge, constructive feedback, and guidance provided credibility and quality
assurance. It is recommended that professionals moving forward with their own training
development seek out content experts and solicit their guidance, feedback, and review of
training materials.
The training described above is scheduled to be delivered to a live audience on
March 2nd, 2023. Evaluative measures will be administered to participants to assess for
participant qualitative experience, quantity and quality of knowledge gained, and
perception of training utility. Measures may include a survey gauging participants’
general reactions to the training (e.g., modules they enjoyed, aspects they wish had been
different, etc.) and a pre and post survey to assess for participant knowledge gained. In
addition, a longitudinal survey may be administered at various time points following the
training to assess for whether or not participants are applying and utilizing the
information learned within their communities and practice. Results from assessment
measures will be utilized to enhance the training for future audiences. In addition,
following the live iteration of this training, our team plans to partner with a larger health
agency to build-out the training in online, asynchronous modules with the goal of
increasing access and promoting widespread training and knowledge.
There are a few limitations that should be noted. First, as discussed above, this
training has not yet been delivered. Thus, conclusions regarding training effectiveness
and utility cannot be drawn. Additionally, this training was developed by a team local to
the state of Colorado. As such, it is possible that there may be a skew in selected content

and discussion based off needs most prevalent to individuals with PSU within Colorado.
Professionals in other states should consider their communities unique needs when
curating material. Finally, this training was designed as an introductory course for a
multidisciplinary audience. Thus, some important, nuances, and detail content not
included. Individuals seeking to gain extensive training in PSU may need additional
training and resources.
In sum, this paper intended to spark inspiration and motivation to disseminate
knowledge regarding PSU. Efforts made to increase knowledge and awareness regarding
PSU will likely decrease shame, stigma, and increase the quality of care for women with
PSU. Moreover, if we work to enhance the systems of care for women and children
impacted by PSU, we have the potential to mitigate against the health risks associated
with PSU, increase the quality of the parent-child relationships, and dismantle
intergenerational patterns of attachment-insecurity, substance misuse, and pain.
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